- Fee assured
- Verified this account
This healthcare professional let us know that they are currently:
- Accepting new patients
- Available for:
- Phone consultations
Last updated: 29 Jun 2020
- Lower GI
- Upper GI
I am a consultant clinical oncologist at the Mount Vernon Cancer Centre. My interests are in the management of upper and lower gastrointestinal malignancies and general/acute oncology. I am able to advise on the treatment for unknown primary cancers and have an interest in both radiotherapy, including stereotactic radiotherapy with cyberknife, and chemotherapy.
I am actively involved with research and recruit and manage patients enrolled in clinical trials. I have several first name publications in peer reviewed journals and have presented on multiple occasions at international conferences.
I qualified from Imperial College London and completed my junior medical training at the Hammersmith and Charing Cross Hospitals. I have completed 7 years of specialist training in north London at Mount Vernon, North Middlesex, Imperial and UCLH. This also included a fellowship in radiotherapy at the Royal Marsden Hospital and a postgraduate Masters degree in Oncology at the Institute of Cancer Research. I am a Member of the Royal College of Physicians and a Fellow of the Royal College of Radiologists. I am also an examiner for the Final Fellowship examination and am very involved in education and specialist training within London.
I live with my family in London, am a keen sports enthusiast and and I am also fluent in Gujarati.
Areas of interest
General Oncology; Intensity Modulated Radiotherapy; Stereotactic Body Radiotherapy, Cyberknife
Current NHS consultant posts held
Consultant Clinical Oncologist
Mount Vernon Cancer Centre
East & North Hertfordshire NHS Trust
Colorectal, Oesophago-gastric and Hepatibiliary malignancies
Charity work in East Africa
Sport, including football, Formula One, Cricket
(Additional) Languages spoken
Whole Brain Radiotherapy for cerebral metastases in advanced non-small cell lung cancer; does it make a difference? An analysis of factors influencing outcomes.
Bhuva N, Buckley H, Ranger A, Goyal N, Koay S, Singer J, Gupta N, Anand G
European Journal of Palliative Care Medicine, Vol. 22 No 5, 214-218
Use of Raltitrexed as an alternative to 5-fluorouracil and Capecitabine in cancer patients with cardiac history.
Kelly C, Bhuva N, Harrison M, Buckley A, Saunders M
European Journal of Cancer, July 2013, Vol. 49 No. 10, 2303-2310
To PET or not to PET? That is the question. Staging in Anal Cancer.
Bhuva N, Glynne-Jones R, Sonoda L, Wong W-L, Harrison M
Annals of Oncology, January 2012, Vol. 23 No. 8, 2078-82
Intraductal tubulopapillary neoplasm of the pancreas as a radiation induced malignancy – a case report.
Bhuva N, Spalding D, Wasan H, Stamp G, Harrison M
BMJ Case Reports, December 2011; Epub doi:10.1136/bcr.09.2011.4777
Living with and beyond cancer: New Challenges
Bhuva N, Li SP, Maher EJ
Topics in Cancer Survivorship edited by R Mohan
January 2012 ISBN 978-953-307-894-6
- Bachelor of Science Imperial College, London 2003
- Bachelor of Medicine, Bachelor of Surgery Imperial College, London 2005
- Master of Science Institute of Cancer Research 2013
- Cyberknife System Product Training - Stereotactic Radiotherapy Accuray 2017
Reference number 6129823
Details of entry to specialist register
- Clinical Oncology, 2016
Affiliations / memberships
Fellow of the Royal College of Radiologists
Member of the Royal College of Physicians
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.